Learn more about the detailed patient points and associated physician data available from OffTheShelf. View our infographic. http://bit.ly/evidera-offtheshelf

Highlights about OffTheShelf™:

• Understanding the market trends, market behavior, and competition when developing oncology therapies is critical to optimize market access and product uptake
• OffTheShelf™ provides access to oncology and hematology patient chart data in 48 hours from 40+ countries across 25+ indications to give you the insights you need to make informed decisions about your product
• HIPAA and GDPR-compliant, OffTheShelf’s data is sourced from healthcare provider EMR databases and provides more than 100 points per patient

This de-identified data includes

• detailed patient profiles
• diagnosis history
• biomarker testing
• adjuvant/neoadjuvant therapy
• complete line of therapy sequencing
• treatment duration by line

• Data can be used to answer key product-related questions, including
  • what are the current treatment patterns for my indication?
  • are there gaps within current guidelines?
  • what products have recently launched and what is the uptake?

Please complete the form below to let us know what kind of OffTheShelf™ data you need to better understand the market behavior and competition surrounding your oncology/hematology therapy: http://bit.ly/evidera-survey